Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Huntington's disease | R-HSA-1643685 | 0 | tetryzoline | 5419 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tetryzoline | 5419 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | tetryzoline | 5419 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | tetryzoline | 5419 | drug-path |
Asthma | R-HSA-444620 | map05310 | tetryzoline | 5419 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | tetryzoline | 5419 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | tetryzoline | 5419 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | tetryzoline | 5419 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tetryzoline | 5419 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | tetryzoline | 5419 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tetryzoline | 5419 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | tetryzoline | 5419 | drug-path |
Shigellosis | 0 | map05131 | lactobionic acid | 7314 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | lactobionic acid | 7314 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | lactobionic acid | 7314 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | lactobionic acid | 7314 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | lactobionic acid | 7314 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | lactobionic acid | 7314 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | lactobionic acid | 7314 | drug-path |
Asthma | R-HSA-444620 | map05310 | lactobionic acid | 7314 | drug-path |